Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASPOFUNGIN vs REZAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASPOFUNGIN vs REZAFUNGIN: Safety Overview

Metric CASPOFUNGIN REZAFUNGIN
Total FAERS Reports 3,814 108
Deaths Reported 1,419 12
Death Rate 37.2% 11.1%
Hospitalizations 1,638 20
Average Patient Age 47.5 yrs 53.8 yrs
% Female Patients 42.8% 54.3%
FDA Approval Date Dec 30, 2016 Mar 22, 2023
Manufacturer Sandoz Inc Melinta Therapeutics, LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription